816449-70-4 Usage
Description
4-Fluoro-3-(methoxycarbonyl)benzyl alcohol, [4-Fluoro-3-(methoxycarbonyl)phenyl]methanol is a pair of closely related organic compounds with similar chemical structures. Both compounds feature a 4-fluoro-3-(methoxycarbonyl)phenyl group, with the former having an additional alcohol group and the latter an extra methanol group. These compounds are widely utilized in organic synthesis and pharmaceutical research, serving as key building blocks for the development of more complex molecules. The presence of fluoro and methoxycarbonyl groups endows them with unique chemical properties, making them valuable assets in medicinal chemistry and drug discovery.
Uses
Used in Organic Synthesis:
4-Fluoro-3-(methoxycarbonyl)benzyl alcohol, [4-Fluoro-3-(methoxycarbonyl)phenyl]methanol is used as a building block in organic synthesis for the creation of more complex molecules. The unique chemical properties of the fluoro and methoxycarbonyl groups allow for versatile reactions and the formation of a wide range of compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-Fluoro-3-(methoxycarbonyl)benzyl alcohol, [4-Fluoro-3-(methoxycarbonyl)phenyl]methanol is used as a key intermediate in the development of new drugs. Their unique structures and properties make them ideal candidates for the design of novel therapeutic agents with potential applications in various medical fields.
Used in Medicinal Chemistry:
4-Fluoro-3-(methoxycarbonyl)benzyl alcohol, [4-Fluoro-3-(methoxycarbonyl)phenyl]methanol is utilized in medicinal chemistry for the exploration of new chemical entities with potential therapeutic effects. 4-Fluoro-3-(methoxycarbonyl)benzyl alcohol, [4-Fluoro-3-(methoxycarbonyl)phenyl]methanols' unique features facilitate the design and optimization of drug candidates, contributing to the advancement of drug discovery efforts.
Used in Drug Discovery:
In drug discovery, 4-Fluoro-3-(methoxycarbonyl)benzyl alcohol, [4-Fluoro-3-(methoxycarbonyl)phenyl]methanol is employed as a valuable tool for identifying and optimizing new drug candidates. Their unique chemical properties make them suitable for the development of innovative therapeutic agents with improved efficacy and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 816449-70-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,6,4,4 and 9 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 816449-70:
(8*8)+(7*1)+(6*6)+(5*4)+(4*4)+(3*9)+(2*7)+(1*0)=184
184 % 10 = 4
So 816449-70-4 is a valid CAS Registry Number.
816449-70-4Relevant articles and documents
COMPOUNDS ACTIVE TOWARDS BROMODOMAINS
-
, (2016/05/02)
Disclosed are compounds towards bromodomains, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
TRICYCLIC DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
Page 65-66, (2010/02/10)
The present invention relates to tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. More precisely, the present invention relates to tricyclic derivatives as colchicine derivatives, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. Tricyclic derivatives of the present invention show very powerful cytotoxicity to cancer cell lines but were much less toxic than colchicine or taxol, confirmed through animal toxicity test. Tricyclic derivatives of the invention also decrease the volume and weight of a tumor and have a strong angiogenesis inhibiting activity in HUVEC cells. Thus, tricyclic derivatives of the present invention can effectively be used as an anticancer agent, anti-proliferation agent and an angiogenesis inhibitor.
